Vaxxinity Inc. Class AVAXX

13F holders, Q3 2025 (September 30)
1holders
1new positions
0sold out
$0.02avg. 13F price*

At the end of Q3 2025, 1 institutions reported holding Vaxxinity Inc. Class A (VAXX) in their 13F filings, unchanged from Q1 2025. 1 opened new positions and 0 sold out. The largest holder was Lanark Financial, Inc. ($31).

Company
Vaxxinity Inc. Class A
CUSIP
92244V104
Latest filing quarter
Q1 2026

History

Number of 13F holders

0204060 Q1 2024: 58Q1 2024Q2 2024: 8Q2 2024Q1 2025: 1Q1 2025Q3 2025: 1Q3 2025Q1 2026: 1Q1 2026

Total Exit/New Position Q1 2025 → Q3 2025

InstitutionsTotal Value
New Positions1$31
Exits0$0

All 13F filers, Q1 2025 → Q3 2025: 1,592 shares bought, net +1,592 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 1 holders

Lanark Financial, Inc. 0.00% New 1,592 $31

"% of holder's portfolio" is VAXX's weight in each manager's 13F, not the share of Vaxxinity Inc. Class A the manager owns.